0001213900-20-037981.txt : 20201118 0001213900-20-037981.hdr.sgml : 20201118 20201118162523 ACCESSION NUMBER: 0001213900-20-037981 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201106 FILED AS OF DATE: 20201118 DATE AS OF CHANGE: 20201118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Feldmann Marc CENTRAL INDEX KEY: 0001832327 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38105 FILM NUMBER: 201325418 MAIL ADDRESS: STREET 1: 5 DURHAM TERRACE CITY: LONDON STATE: X0 ZIP: W25PB ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 180 Life Sciences Corp. CENTRAL INDEX KEY: 0001690080 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813832378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 WEST 56TH STREET SUITE 5901 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-319-5555 MAIL ADDRESS: STREET 1: 150 WEST 56TH STREET SUITE 5901 CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: KBL MERGER CORP. IV DATE OF NAME CHANGE: 20161115 3 1 ownership.xml X0206 3 2020-11-06 0 0001690080 180 Life Sciences Corp. ATNF 0001832327 Feldmann Marc 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 1 0 1 0 Common Stock 2596848 D /s/ Sir Marc Feldmann, Ph.D. 2020-11-18